- Home
- AGCO vs JAZZ Comparison
AGCO vs JAZZ Comparison
Compare AGCO & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGCO
- JAZZ
- Stock Information
- Founded
- AGCO 1990
- JAZZ 2003
- Country
- AGCO United States
- JAZZ Ireland
- Employees
- AGCO N/A
- JAZZ N/A
- Industry
- AGCO Industrial Machinery/Components
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- AGCO Industrials
- JAZZ Health Care
- Exchange
- AGCO Nasdaq
- JAZZ Nasdaq
- Market Cap
- AGCO 6.8B
- JAZZ 7.3B
- IPO Year
- AGCO 1992
- JAZZ 2007
- Fundamental
- Price
- AGCO $100.45
- JAZZ $108.07
- Analyst Decision
- AGCO Buy
- JAZZ Strong Buy
- Analyst Count
- AGCO 11
- JAZZ 13
- Target Price
- AGCO $101.50
- JAZZ $181.85
- AVG Volume (30 Days)
- AGCO 862.7K
- JAZZ 1.4M
- Earning Date
- AGCO 05-01-2025
- JAZZ 05-06-2025
- Dividend Yield
- AGCO 1.15%
- JAZZ N/A
- EPS Growth
- AGCO N/A
- JAZZ 49.21
- EPS
- AGCO N/A
- JAZZ 7.51
- Revenue
- AGCO $10,783,700,000.00
- JAZZ $4,064,808,000.00
- Revenue This Year
- AGCO N/A
- JAZZ $5.92
- Revenue Next Year
- AGCO $5.57
- JAZZ $4.22
- P/E Ratio
- AGCO N/A
- JAZZ $14.39
- Revenue Growth
- AGCO N/A
- JAZZ 5.76
- 52 Week Low
- AGCO $73.79
- JAZZ $95.49
- 52 Week High
- AGCO $108.92
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- AGCO 55.07
- JAZZ 47.66
- Support Level
- AGCO $103.47
- JAZZ $103.60
- Resistance Level
- AGCO $107.58
- JAZZ $112.13
- Average True Range (ATR)
- AGCO 2.46
- JAZZ 4.48
- MACD
- AGCO -0.09
- JAZZ 0.76
- Stochastic Oscillator
- AGCO 46.22
- JAZZ 51.56
About AGCO AGCO Corporation
Agco is a global manufacturer of agricultural equipment. The company has five core brands: Fendt, Massey Ferguson, Challenger, Valtra, and GSI. Unlike its competitors, Agco's product line extends beyond self-propelled equipment and implements to grain handling systems and livestock management solutions. Its products are available through a global dealer network, which includes about 3,100 dealer and distribution locations. Agco offers retail and wholesale financing to customers through its joint venture with Rabobank, a European food- and agriculture-focused bank.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.